Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
CluePoints
Risk-based quality management and central statistical monitoring platform for clinical trial data oversight.
CluePoints provides risk-based quality management and central statistical monitoring software for clinical trials. Its platform analyzes accumulating study data to flag anomalies, quality issues, and emerging risks across sites, helping sponsors and CROs focus monitoring effort where it matters and maintain data integrity throughout a study. In 2024 private-equity firm EQT acquired a majority stake in CluePoints.
- Headquarters
- Louvain-la-Neuve, Belgium
- Founded
- 2012
- Deployment options
- cloud
- Website
- https://cluepoints.com
- https://www.linkedin.com/company/cluepoints
Categories
AI Use Cases
- Clinical Data Management
- Medical Monitoring & Safety Review
Vendor Scorecard
79% — Complete coverage. Coverage score — how completely Atlas documents CluePoints across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Deployment & Hosting — Documented
cloud
Pricing Transparency — Documented
Per study / enterprise license
Implementation & Onboarding — Documented
3–6 months
Organization & Role Fit — Documented
Mid-Size Biotech, Large Pharma, Top 20 Pharma, CRO / CDMO, Clinical Operations, Data Management
Solution Scope — Documented
Clinical Data Management
Company Viability — Partially documented
Private equity, Founded 2012
Always ask the vendor
Not captured in Atlas data — confirm directly. Excluded from the score above.
Data Rights & IP
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Model Credibility & Explainability
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?
Evidence & Outcomes
CluePoints recognized with a 2025 Scrip Award
CluePoints was recognized with a 2025 Scrip Award, cited as a risk-based quality management and AI leader in clinical development.
press release (CluePoints (PR Newswire)) · 2025-12-12
Questions to Ask This Vendor
- How does central statistical monitoring integrate with our existing EDC and CTMS?
- What risk indicators are configurable for our therapeutic area?
- How are flagged signals triaged and actioned by monitoring teams?
- What validation documentation is available for regulated studies?